Lemtrada

Alemtuzumab (Lemtrada) is a recombinant humanized IgG1 kappa monoclonal antibody to the surface cell glycoprotein, a CD52… Expand

Background There is a significant UK variation in the DMT sequencing strategies for high PML risk patients on Tysabri. In Greater… Expand

 

 

Stwardnienie rozsiane cześciej wystepuje u kobiet, a szczyt zachorowan przypada na wiek rozrodczy. Dlatego zagadnienie ciązy w… Expand

From 1 April 2015, Lemtrada (alemtuzumab) became available in Australia on the PBS for the treatment of relapsing forms of… Expand

NEW DRUG APPROVALS Blincyto for Rare Form of ALL The FDA has approved blinatumomab (Blincyto, Amgen) to treat patients with… Expand

Those who have already received a course of the drug need access until its re-release